Pancoast (Superior Sulcus) Tumors

Slides:



Advertisements
Similar presentations
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Advertisements

Photodynamic Laser Therapy for Lesions in the Airway
Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Magnitude of Negative Impact of Preoperative Heart Failure on Mortality During Aortic Valve Replacement in the Medicare Population  Christina M. Vassileva,
Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database  Daniel J. Boffa,
Adjuvant Chemotherapy for T3 Non–Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe  Michelle C. Salazar, MD, Joshua E. Rosen, BASc,
Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non- Small Cell Lung Cancer  Ken Kodama, MD, Masahiko Higashiyama, MD, Jiro.
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Changes in the treatment of Pancoast tumors
A Strategy for Supraclavicular Lymph Node Dissection Using Recurrent Laryngeal Nerve Lymph Node Status in Thoracic Esophageal Squamous Cell Carcinoma 
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Andranik Petrosyan, MD, Patrice Bergeron, MD 
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.
Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma  Sina Ercan, MD, Francis C Nichols,
Increased Exposure Improves Recruitment: Early Results of a Program Designed to Attract Medical Students Into Surgical Careers  Kara A. Haggerty, BA,
Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease  Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Intensive chemotherapy and radical resections for primary nonseminomatous mediastinal germ cell tumors  Garrett L Walsh, MD, Grant D Taylor, BS, Jonathan.
Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer  Justin A. Drake, MD, David C. Portnoy, MD, Kurt.
Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases  Haifeng Wang, MM, Hongsheng Lin, MM, Gening.
Superior sulcus (Pancoast) tumor: experience with 105 patients
Mark K Ferguson, MD, Amy G Lehman, BA  The Annals of Thoracic Surgery 
Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer  Anthony W.
Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma  Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.
Early pulmonary resection for localized mycobacterium avium complex disease  Yuji Shiraishi, MD, Kanae Fukushima, MD, Hikotaro Komatsu, MD, Atsuyuki Kurashima,
Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long- Term Outcomes  Domenico Galetta, MD, PhD, Piergiorgio Solli, MD,
Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma  Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.
Use of Amiodarone After Major Lung Resection
Long-term results after pulmonary resection of renal cell carcinoma metastases  Stefan Piltz, MD, Georgios Meimarakis, MD, Matthias W Wichmann, MD, Rudolf.
Outcomes After Extrapleural Pneumonectomy and Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma  David C. Rice, MB, BCh, Craig.
Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.
Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy  Shizuka Kaseda, MD, Teruhiro Aoki, MD, Nanae Hangai,
Prolonged Overall Survival After Pulmonary Metastasectomy in Patients With Breast Cancer  Georgios Meimarakis, MD, Dominik Rüttinger, MD, PhD, Joachim.
Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases  Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.
Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy  Feng Wang, MD, Yuzhen Zheng, MD, Zhen Wang,
Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD 
Importance of Lymph Node Dissection in Thymic Carcinoma
Pulmonary Resection for Lung Cancer in Octogenarians
Intrathoracic Lymph Node Metastases From Extrathoracic Carcinoma: The Place for Surgery  Marc Riquet, MD, Pascal Berna, MD, Emmanuel Brian, MD, Alain.
High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma  Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.
Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer  Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.
Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence  Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,
Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival  Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,
Frank C. Detterbeck, MD  The Annals of Thoracic Surgery 
Is there a role for pneumonectomy in pulmonary metastases?1
Superior sulcus lung tumors: Impact of local control on survival
Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma  Scott.
Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study  Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,
Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D
Benny Weksler, MD, Manisha Shende, MD, Katie S
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors  Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.
Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter?  Anthony W. Kim, MD, L. Penfield Faber, MD, William.
Mediastinal Paragangliomas: The Mayo Clinic Experience
Predictors of Pleural Implants in Patients With Thymic Tumors
Survival Benefits of Postoperative Chemoradiation for Lymph Node–Positive Esophageal Squamous Cell Carcinoma  Po-Kuei Hsu, MD, Chien-Sheng Huang, MD,
Minimally invasive resection of mediastinal parathyroid adenomas
Mark I. Block, MD  The Annals of Thoracic Surgery 
Lobectomy Versus Limited Resection in T1N0 Lung Cancer
Bronchial Sleeve Resection Distal to the Main Bronchus With Complete Pulmonary Preservation for Benign or Low-Grade Malignant Tumors  Xingtao Jiang, Xiaopeng.
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Treating Locally Advanced Disease: An Analysis of Very Large, Hilar Lymph Node Positive Non-Small Cell Lung Cancer Using the National Cancer Data Base 
Survival of Patients With Unsuspected pN2 Non-Small Cell Lung Cancer After an Accurate Preoperative Mediastinal Staging  Carme Obiols, MD, Sergi Call,
Presentation transcript:

Pancoast (Superior Sulcus) Tumors Frank C. Detterbeck, MD  The Annals of Thoracic Surgery  Volume 63, Issue 6, Pages 1810-1818 (June 1997) DOI: 10.1016/S0003-4975(97)00360-3

Fig. 1 Nerve involvement in a typical Pancoast tumor (C8, T1, T2, lower trunk of brachial plexus, sympathetic chain). The dermatomes of C8 and T1 are illustrated, as well as areas of referred pain in the scapular and pectoral regions (mediated through afferent fibers of the sympathetic chain). The Annals of Thoracic Surgery 1997 63, 1810-1818DOI: (10.1016/S0003-4975(97)00360-3)

Fig. 2 Survival curves of patients with Pancoast tumors who had only pleural invasion compared with those who had vascular invasion, bone invasion, or both (p = 0.003). (Reprinted with permission from Sartori F, Rea F, Calabrı̈ F, Mazzucco C, Bortolotti L, Tomio L. Carcinoma of the superior pulmonary sulcus: results of irradiation and radical resection. J Thorac Cardiovasc Surg 1992;104:679–83.) The Annals of Thoracic Surgery 1997 63, 1810-1818DOI: (10.1016/S0003-4975(97)00360-3)

Fig. 3 (A) Survival by nodal status for entire patient cohort. (B) Survival by nodal status for patients with completely resected disease. (Reprinted with permission from The Society of Thoracic Surgeons [Ann Thorac Surg 1994;57:1440–5].) The Annals of Thoracic Surgery 1997 63, 1810-1818DOI: (10.1016/S0003-4975(97)00360-3)

Fig. 4 Survival according to mediastinal node status in 128 patients with superior sulcus tumors who received or did not receive preoperative radiation therapy (preop RT). Squares indicate preoperative radiation therapy, nodes negative, n = 70; “x”’s indicate no preoperative radiation therapy, nodes negative, n = 39; triangles indicate preoperative radiation therapy, nodes positive, n = 12; and underlined “x”’s indicate no preoperative radiation therapy, nodes positive, n = 7. (neg = negative; pos = positive.) (Reprinted with permission from Hilaris BS, Martini N, Wong GY, Nori D. Treatment of superior sulcus tumor (Pancoast tumor). Surg Clin North Am 1987;67:965–77.) The Annals of Thoracic Surgery 1997 63, 1810-1818DOI: (10.1016/S0003-4975(97)00360-3)

Fig. 5 Survival rates for patients with completely resected disease according to type of pulmonary resection. (Reprinted with permission from The Society of Thoracic Surgeons [Ann Thorac Surg 1994;57:1440–5].) The Annals of Thoracic Surgery 1997 63, 1810-1818DOI: (10.1016/S0003-4975(97)00360-3)

Fig. 6 Survival of 124 patients with superior sulcus tumors. The asterisk indicates an incomplete resection curve estimated from reported data of the overall group, and those with complete resection or no resection. (Adapted with permission from The Society of Thoracic Surgeons [Ann Thorac Surg 1994;57:1440–5].) The Annals of Thoracic Surgery 1997 63, 1810-1818DOI: (10.1016/S0003-4975(97)00360-3)